Weight loss drugs like Ozempic and Wegovy are all the rage, but not everyone can afford them, and not everyone needs them to ...

As India awaits the launch of obesity drug, Mounjaro, the debate on weight loss drugs and body image continues ...

GLP-1 receptor agonists, initially developed for type 2 diabetes treatment, work by mimicking a naturally occurring gut ...

But 25-year-old Madison Burgess has thrown caution to the wind by opting to micro-dose the drug. The Michigan native revealed ...

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

Ozempic, and Rybelsus and similar drugs like Moujaro and Zepbound. And just like all the other weight loss fads and trends, people gain the weight back after they stop taking the drug. One recent ...

The company created its GLP-1 Insurance Checker specifically to help you determine your coverage on popular weight loss drugs like Ozempic, Wegovy, and Zepbound. If you're new to Ro, they'll even ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...

The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...

Trump directed a panel headed by HHS Secretary Robert F. Kennedy Jr. to assess “the prevalence of and threat” posed by SSRIs, ...

Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply, the FDA declared ...